Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

MCNEX Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

MCNEX has a total shareholder equity of ₩346.7B and total debt of ₩91.9B, which brings its debt-to-equity ratio to 26.5%. Its total assets and total liabilities are ₩558.9B and ₩212.2B respectively. MCNEX's EBIT is ₩40.6B making its interest coverage ratio 19.7. It has cash and short-term investments of ₩31.0B.

Anahtar bilgiler

26.5%

Borç/özkaynak oranı

₩91.87b

Borç

Faiz karşılama oranı19.7x
Nakit₩30.97b
Eşitlik₩346.73b
Toplam yükümlülükler₩212.16b
Toplam varlıklar₩558.89b

Son finansal sağlık güncellemeleri

Recent updates

Returns On Capital Signal Tricky Times Ahead For MCNEX (KRX:097520)

Apr 30
Returns On Capital Signal Tricky Times Ahead For MCNEX (KRX:097520)

These 4 Measures Indicate That MCNEX (KOSDAQ:097520) Is Using Debt Reasonably Well

May 06
These 4 Measures Indicate That MCNEX (KOSDAQ:097520) Is Using Debt Reasonably Well

Is There An Opportunity With MCNEX Co., Ltd's (KOSDAQ:097520) 25% Undervaluation?

Apr 14
Is There An Opportunity With MCNEX Co., Ltd's (KOSDAQ:097520) 25% Undervaluation?

Why You Should Care About MCNEX's (KOSDAQ:097520) Strong Returns On Capital

Mar 21
Why You Should Care About MCNEX's (KOSDAQ:097520) Strong Returns On Capital

Is MCNEX's (KOSDAQ:097520) Share Price Gain Of 281% Well Earned?

Mar 08
Is MCNEX's (KOSDAQ:097520) Share Price Gain Of 281% Well Earned?

What You Need To Know About MCNEX Co., Ltd's (KOSDAQ:097520) Investor Composition

Feb 24
What You Need To Know About MCNEX Co., Ltd's (KOSDAQ:097520) Investor Composition

Would MCNEX Co., Ltd (KOSDAQ:097520) Be Valuable To Income Investors?

Feb 12
Would MCNEX Co., Ltd (KOSDAQ:097520) Be Valuable To Income Investors?

We Think MCNEX (KOSDAQ:097520) Is Taking Some Risk With Its Debt

Feb 01
We Think MCNEX (KOSDAQ:097520) Is Taking Some Risk With Its Debt

Is MCNEX Co., Ltd (KOSDAQ:097520) Potentially Undervalued?

Jan 21
Is MCNEX Co., Ltd (KOSDAQ:097520) Potentially Undervalued?

Is There An Opportunity With MCNEX Co., Ltd's (KOSDAQ:097520) 32% Undervaluation?

Jan 10
Is There An Opportunity With MCNEX Co., Ltd's (KOSDAQ:097520) 32% Undervaluation?

Are Robust Financials Driving The Recent Rally In MCNEX Co., Ltd's (KOSDAQ:097520) Stock?

Dec 29
Are Robust Financials Driving The Recent Rally In MCNEX Co., Ltd's (KOSDAQ:097520) Stock?

We Wouldn't Rely On MCNEX's (KOSDAQ:097520) Statutory Earnings As A Guide

Dec 18
We Wouldn't Rely On MCNEX's (KOSDAQ:097520) Statutory Earnings As A Guide

Can MCNEX (KOSDAQ:097520) Keep Up These Impressive Returns?

Dec 07
Can MCNEX (KOSDAQ:097520) Keep Up These Impressive Returns?

Did Business Growth Power MCNEX's (KOSDAQ:097520) Share Price Gain of 190%?

Nov 26
Did Business Growth Power MCNEX's (KOSDAQ:097520) Share Price Gain of 190%?

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: A097520's short term assets (₩292.0B) exceed its short term liabilities (₩208.2B).

Uzun Vadeli Yükümlülükler: A097520's short term assets (₩292.0B) exceed its long term liabilities (₩3.9B).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: A097520's net debt to equity ratio (17.6%) is considered satisfactory.

Borcun Azaltılması: A097520's debt to equity ratio has reduced from 58.7% to 26.5% over the past 5 years.

Borç Kapsamı: A097520's debt is well covered by operating cash flow (20.4%).

Faiz Kapsamı: A097520's interest payments on its debt are well covered by EBIT (19.7x coverage).


Bilanço


Sağlıklı şirketleri keşfedin